-
公开(公告)号:US09085622B2
公开(公告)日:2015-07-21
申请号:US13639918
申请日:2011-09-02
申请人: Neil James Clarke , Kyung Oh Johanson , Zdenka Ludmila Jonak , Alexander H. Taylor , Christopher B. Hopson , Stephen H. Trulli , Zdenka Haskova , Judithann M. Lee , John R. White , Yu Xue
发明人: Neil James Clarke , Kyung Oh Johanson , Zdenka Ludmila Jonak , Alexander H. Taylor , Christopher B. Hopson , Stephen H. Trulli , Zdenka Haskova , Judithann M. Lee , John R. White , Yu Xue
IPC分类号: C07K16/28 , A61K39/395 , C07K16/32 , A61K39/00
CPC分类号: C07K16/28 , A61K2039/505 , C07K16/32 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/72 , C07K2317/732 , C07K2317/734 , C07K2317/77 , C07K2317/92
摘要: The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.
摘要翻译: 本公开涉及结合HER3的抗原结合蛋白,例如抗体,编码这种抗原结合蛋白的多核苷酸,包含所述抗原结合蛋白的药物组合物和制备方法。 本公开还涉及这种抗原结合蛋白在治疗或预防与乳腺癌,卵巢癌,前列腺癌,膀胱癌,胰腺,胃癌,黑素瘤和其它过表达HER3的癌症相关的疾病中的用途。
-
公开(公告)号:US20130156779A1
公开(公告)日:2013-06-20
申请号:US13639918
申请日:2011-09-02
申请人: Neil James Clarke , Kyung Oh Johanson , Zdenka Ludmila Jonak , Alexander H. Taylor , Christopher B. Hopson , Stephen H. Trulli , Zdenka Haskova , Judithann M. Lee , John R. White , Yu Xue
发明人: Neil James Clarke , Kyung Oh Johanson , Zdenka Ludmila Jonak , Alexander H. Taylor , Christopher B. Hopson , Stephen H. Trulli , Zdenka Haskova , Judithann M. Lee , John R. White , Yu Xue
IPC分类号: C07K16/28
CPC分类号: C07K16/28 , A61K2039/505 , C07K16/32 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/72 , C07K2317/732 , C07K2317/734 , C07K2317/77 , C07K2317/92
摘要: The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.
摘要翻译: 本公开涉及结合HER3的抗原结合蛋白,例如抗体,编码这种抗原结合蛋白的多核苷酸,包含所述抗原结合蛋白的药物组合物及其制备方法。 本公开还涉及这种抗原结合蛋白在治疗或预防与乳腺癌,卵巢癌,前列腺癌,膀胱癌,胰腺,胃癌,黑素瘤和其它过表达HER3的癌症相关的疾病中的用途。
-
公开(公告)号:US20120282254A1
公开(公告)日:2012-11-08
申请号:US13574847
申请日:2011-01-26
申请人: Ian Kirby , Alexander H. Taylor , Thomas Matthew Webb , Yu Xue
发明人: Ian Kirby , Alexander H. Taylor , Thomas Matthew Webb , Yu Xue
IPC分类号: C07K16/46 , C12N15/63 , C12P21/08 , A61K39/395 , C07K16/28 , C12N5/10 , A61P37/06 , A61P29/00 , C12N1/21 , C12N1/19 , C12N1/15 , C12N15/62 , A61P25/00
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/24 , C07K2317/76 , C07K2317/92
摘要: Antigen binding proteins which bind to human IL-7 receptor (CD127) are provided. The antigen binding proteins are typically antibodies, and are useful in the treatment of diseases or disorders in humans, particularly autoimmune diseases such as multiple sclerosis.
摘要翻译: 提供了结合人IL-7受体(CD127)的抗原结合蛋白。 抗原结合蛋白通常是抗体,并且可用于治疗人类的疾病或病症,特别是自身免疫性疾病如多发性硬化症。
-
公开(公告)号:US09150653B2
公开(公告)日:2015-10-06
申请号:US13574847
申请日:2011-01-26
申请人: Ian Kirby , Alexander H. Taylor , Thomas Matthew Webb , Yu Xue
发明人: Ian Kirby , Alexander H. Taylor , Thomas Matthew Webb , Yu Xue
IPC分类号: C07K16/46 , A61K39/395 , C07K16/28 , A61P37/06 , C12N1/15 , C12N15/62 , C12P21/08 , A61K39/00
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/24 , C07K2317/76 , C07K2317/92
摘要: Antigen binding proteins which bind to human IL-7 receptor (CD127) are provided. The antigen binding proteins are typically antibodies, and are useful in the treatment of diseases or disorders in humans, particularly autoimmune diseases such as multiple sclerosis.
摘要翻译: 提供了结合人IL-7受体(CD127)的抗原结合蛋白。 抗原结合蛋白通常是抗体,并且可用于治疗人类的疾病或病症,特别是自身免疫性疾病如多发性硬化症。
-
公开(公告)号:US06936698B2
公开(公告)日:2005-08-30
申请号:US09905243
申请日:2001-07-16
申请人: Alexander H. Taylor
发明人: Alexander H. Taylor
IPC分类号: C12N15/09 , A61K39/395 , A61P37/02 , C07H21/04 , C07K16/00 , C07K16/18 , C07K16/24 , C07K16/28 , C07K16/42 , C12N5/06 , C12P21/06 , C12P21/08
CPC分类号: C07K16/2848 , C07K16/00 , C07K16/244 , C07K16/2863 , C07K2317/21 , C07K2317/24 , C07K2317/567 , C07K2319/00
摘要: Antibodies having reduced immunogenicity and methods for making them are disclosed.
-
公开(公告)号:US10392625B2
公开(公告)日:2019-08-27
申请号:US13203056
申请日:2010-02-24
申请人: Yong Hwan Jin , James D. Jowett , Alexander H. Taylor , Yuan Zhu
发明人: Yong Hwan Jin , James D. Jowett , Alexander H. Taylor , Yuan Zhu
IPC分类号: C07K14/00 , C12N15/81 , C07K14/605 , C12N9/10 , C12N9/60
摘要: The present invention provides genetically modified Pichia strains wherein at least one nucleic acid sequence encoding a functional gene product and/or at least one nucleic acid sequence necessary for expression of at least one functional gene product in said Pichia strain is genetically modified, wherein said gene product is responsible for proteolysis and/or glycosylation in said genetically modified Pichia strain. In particular, Pichia strains are provided wherein nucleic acid sequence encoding a functional gene product or expression of said gene product are genetically modified: PEP4, PRB1, YPS1, YPS2, YMP1, YMP2, YMP3 and PMT4. Also provided herein are genetically modified host cells wherein wild type parent of said genetically modified host cell comprises a gene encoding a polypeptide having at least 60% sequence identity to amino acids 1-865 of SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8 wherein said gene is genetically modified in the genome of said host cell such that the gene product is reduced or eliminated in said genetically modified host cell compared with said wild type host cell.
-
公开(公告)号:US20120142895A1
公开(公告)日:2012-06-07
申请号:US13203056
申请日:2010-02-24
申请人: Yong Hwan Jin , James D. Jowett , Alexander H. Taylor , Yuan Zhu
发明人: Yong Hwan Jin , James D. Jowett , Alexander H. Taylor , Yuan Zhu
CPC分类号: C12N15/815 , C07K14/605 , C07K2319/31 , C12N9/1051 , C12N9/60
摘要: The present invention provides genetically modified Pichia strains wherein at least one nucleic acid sequence encoding a functional gene product and/or at least one nucleic acid sequence necessary for expression of at least one functional gene product in said Pichia strain is genetically modified, wherein said gene product is responsible for proteolysis and/or glycosylation in said genetically modified Pichia strain. In particular, Pichia strains are provided wherein nucleic acid sequence encoding a functional gene product or expression of said gene product are genetically modified: PEP4, PRB1, YPS1, YPS2, YMP1, YMP2, YMP3 and PMT4. Also provided herein are genetically modified host cells wherein wild type parent of said genetically modified host cell comprises a gene encoding a polypeptide having at least 60% sequence identity to amino acids 1-865 of SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8 wherein said gene is genetically modified in the genome of said host cell such that the gene product is reduced or eliminated in said genetically modified host cell compared with said wild type host cell.
摘要翻译: 本发明提供了遗传修饰的毕赤酵母菌株,其中至少一个编码功能性基因产物的核酸序列和/或在所述毕赤酵母属菌株中表达至少一种功能性基因产物所必需的至少一种核酸序列被遗传修饰,其中所述基因 产物负责所述遗传修饰的毕赤酵母菌株中的蛋白水解和/或糖基化。 具体而言,提供了编码功能性基因产物的核酸序列或所述基因产物的表达被遗传修饰的毕赤酵母菌株:PEP4,PRB1,YPS1,YPS2,YMP1,YMP2,YMP3和PMT4。 本文还提供遗传修饰的宿主细胞,其中所述经遗传修饰的宿主细胞的野生型亲本包含编码与SEQ ID NO:4,SEQ ID NO:6的氨基酸1-865至少60%序列同一性的多肽的基因和 SEQ ID NO:8,其中所述基因在所述宿主细胞的基因组中被遗传修饰,使得与所述野生型宿主细胞相比,在所述遗传修饰的宿主细胞中基因产物被还原或消除。
-
公开(公告)号:US06432678B1
公开(公告)日:2002-08-13
申请号:US09597576
申请日:2000-06-20
申请人: Alexander H. Taylor , Han N. Trinh
发明人: Alexander H. Taylor , Han N. Trinh
IPC分类号: C12P2100
CPC分类号: C07K14/54 , C07K2319/30
摘要: Macaca cynomolgus IL18 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize Macaca cynomolgus IL18. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: cancer and auto-immune diseases.
摘要翻译: 公开了猕猴猕猴IL18多肽和多核苷酸以及通过重组技术产生这种多肽的方法。 还公开了用于筛选激化或拮抗猕猴猕猴IL18的化合物的方法。 预期这些化合物可用于治疗人类疾病,包括但不限于:癌症和自身免疫性疾病。
-
公开(公告)号:US20120196372A1
公开(公告)日:2012-08-02
申请号:US13362362
申请日:2012-01-31
IPC分类号: C12N15/70
摘要: The present invention relates to methods of preventing glyconoylation of polypeptides produced in micororganisms.
摘要翻译: 本发明涉及防止在微生物中产生的多肽的糖缩酰化的方法。
-
公开(公告)号:US08173396B2
公开(公告)日:2012-05-08
申请号:US10547860
申请日:2004-03-04
摘要: The present invention relates to methods of preventing glyconoylation of polypeptides produced in micororganisms.
摘要翻译: 本发明涉及防止在微生物中产生的多肽的糖缩酰化的方法。
-
-
-
-
-
-
-
-
-